BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18054068)

  • 1. Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim HS; Tayebjee MH; Tan KT; Patel JV; Macfadyen RJ; Lip GY
    Thromb Res; 2008; 122(3):307-13. PubMed ID: 18054068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
    Choudhury A; Freestone B; Patel J; Lip GY
    Chest; 2007 Dec; 132(6):1913-9. PubMed ID: 18079224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis.
    Patel JV; Lim HS; Nadar S; Tayebjee M; Hughes EA; Lip GY
    J Hypertens; 2006 Jan; 24(1):117-21. PubMed ID: 16331109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
    Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
    Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.
    Rondina MT; Lappé JM; Carlquist JF; Muhlestein JB; Kolek MJ; Horne BD; Pearson RR; Anderson JL
    Cardiology; 2008; 109(3):196-201. PubMed ID: 17726321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating biomarkers of angiogenesis as indicators of left ventricular systolic dysfunction amongst patients with coronary artery disease.
    Patel JV; Abraheem A; Chackathayil J; Gunning M; Creamer J; Hughes EA; Lip GY
    J Intern Med; 2009 May; 265(5):562-7. PubMed ID: 19187100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related change of serum angiogenic factor levels in patients with coronary artery disease.
    Meng R; Pei Z; Chen B; Ma R; Zhang C; Chen B; Zhang A; Wu T; Liu D; Dong Y
    Acta Cardiol; 2009 Dec; 64(6):735-40. PubMed ID: 20128148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
    Lim HS; Lip GY; Blann AD
    Atherosclerosis; 2005 May; 180(1):113-8. PubMed ID: 15823283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW; Lip GY; Blann AD
    Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
    Lim HS; Blann AD; Chong AY; Freestone B; Lip GY
    Diabetes Care; 2004 Dec; 27(12):2918-24. PubMed ID: 15562207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
    Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
    Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD40 ligand is associated with angiographic severity of coronary artery disease in patients with acute coronary syndrome.
    Zhao W; Zhang F; Li Z; Yu H; Li Z; Gao W
    Chin Med J (Engl); 2014; 127(12):2218-21. PubMed ID: 24931231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis.
    Kurosaka D; Hirai K; Nishioka M; Miyamoto Y; Yoshida K; Noda K; Ukichi T; Yanagimachi M; Furuya K; Takahashi E; Kingetsu I; Fukuda K; Yamada A
    J Rheumatol; 2010 Jun; 37(6):1121-8. PubMed ID: 20436077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma.
    Tsirakis G; Pappa CA; Psarakis FE; Fragioudaki M; Tsioutis C; Stavroulaki E; Boula A; Alexandrakis MG
    Med Oncol; 2012 Dec; 29(4):2396-401. PubMed ID: 22403003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.